retatrutide type 2 diabetes trial 2024 Effects of on body composition in people with diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised 🚨Breaking: Retatrutide's first Phase 3

Industry observers expect that Eli Lilly may apply for FDA approval after the completion of its Phase 3 trials, which could place potential FDA approval in late 2026 or 2027

Should I train on injection days

Keep vials upright and protected from light

Benefits of Weight Loss for the Heart Reduced strain on the heart muscle Lower systolic and diastolic blood pressure Improved cholesterol profiles (increased HDL, decreased LDL and triglycerides) Reduced risk of heart disease and stroke How GLP-1 Medications Support More Than Weight Loss GLP-1 receptor agonists such as semaglutide and tirzepatide were originally developed to support blood sugar control